AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Feb 24, 2025
31676_dirs_2025-02-24_4fcea755-032b-4162-8982-ec9778177a36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-02-21
Reporting Person: Davis Krista (SVP, CHIEF HR OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-21 | Common Stock | S | 1000 | $60.20 | Disposed | 68624 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3